60
Views
1
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Single nucleotide polymorphisms rs12979860 and rs8099917 in IL-28B and spontaneous clearance of hepatitis C genotype 4

ORCID Icon, &
Pages 91-93 | Received 18 Aug 2019, Accepted 09 Oct 2019, Published online: 13 Nov 2019

References

  • Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107–115.
  • Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006;13:34–41.
  • Lyra AC, Ramrakhiani S, Bacon BR, et al. Infection with hepatitis C virus genotype 4 in the United States. J Clin Gastroenterol. 2004;38:68–71.
  • Kempuraj D, Donelan J, Frydas S, et al. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol. 2004;17:103–106.
  • Zheng H, Li M, Chi B, et al. IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated interferon and ribavirin in chronic hepatitis C patients: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:576–583.
  • Pár A, Pár G, Tornai I, et al. IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection. Orv Hetil. 2013;154:1261–1268.
  • Attallah AM, Omran D, Marie MS, et al. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. BrJ Biomed Sci. 2018;75:157–162.
  • Stattermayer AF, Stauber R, Hofer H, et al. Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2011;9:344–350.e2.
  • Rallon NI, Naggie S, Benito JM, et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-co infected patients. AIDS. 2010;24:F23–29.
  • Rauch A, Kutalik Z, Descombes P, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure - A genome-wide association study. Gastroenterology. 2010;138:1338–1345. 1345.e1–7.
  • Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology 2010;139:1865–1876.
  • Schaefer EA, Chung RT. The impact of human gene polymorphisms on HCV infection and disease outcome. Semin Liver Dis. 2011;31:375–386.
  • Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100–1104.
  • Hézode C, Fontaine H, Dorival C, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. J Hepatol. 2013;59:434–441.
  • Wysocka-Leszczyńska J, Ewelina K, Świątek-Kościelna B, et al. Distribution of polymorphisms rs12979860, rs8099917 and rs12980275 IL28B in patients with chronic hepatitis C. Adv Clin Exp Med. 2017;26:1257–1261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.